WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010115719) QUINOXALINE DERIVATIVES AND THEIR USE FOR TREATING BENIGN AND MALIGNANT TUMOUR DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/115719    International Application No.:    PCT/EP2010/053891
Publication Date: 14.10.2010 International Filing Date: 25.03.2010
Chapter 2 Demand Filed:    21.01.2011    
IPC:
C07D 241/44 (2006.01), C07D 401/12 (2006.01), C07D 409/12 (2006.01), C07D 413/12 (2006.01), A61K 31/498 (2006.01), A61P 35/00 (2006.01), C07D 403/04 (2006.01), A61K 31/5377 (2006.01)
Applicants: ÆTERNA ZENTARIS GMBH [DE/DE]; Weismüllerstraße 50 60314 Frankfurt am Main (DE) (For All Designated States Except US)
Inventors: GERLACH, Matthias; (DE).
SEIPELT, Irene; (DE).
GÜNTHER, Eckhard; (DE).
SCHUSTER, Tilmann; (DE).
POLYMEROPOULOS, Emmanuel; (DE).
CZECH, Michael; (DE).
CLAUS, Eckhard; (DE)
Priority Data:
09157141.4 02.04.2009 EP
61/165,953 02.04.2009 US
Title (EN) QUINOXALINE DERIVATIVES AND THEIR USE FOR TREATING BENIGN AND MALIGNANT TUMOUR DISORDERS
(FR) DÉRIVÉS DE QUINOXALINE ET LEUR UTILISATION POUR TRAITER DES TROUBLES DUS À DES TUMEURS BÉNIGNES OU MALIGNES
Abstract: front page image
(EN)The invention provides quinoxalines of the general formula I which are used as medicaments preferably for treating tumour disorders, in particular in cases of drug resistance to other active compounds and in cases of metastasic carcinoma. The possible applications are not limited to tumour disorders (Formula I).
(FR)L'invention porte sur des quinoxalines de la formule générale I, qui sont utilisées comme médicaments, de préférence pour traiter des troubles dus à une tumeur, en particulier dans des cas de résistance à d'autres composés actifs administrés comme médicaments et dans des cas de carcinome métastasique. Les applications possibles ne sont pas limitées aux troubles dus à une tumeur (Formule I).
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)